R. H. Strasser

895 total citations
36 papers, 470 citations indexed

About

R. H. Strasser is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, R. H. Strasser has authored 36 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in R. H. Strasser's work include Acute Kidney Injury Research (5 papers), Cardiovascular Function and Risk Factors (4 papers) and Cardiac Valve Diseases and Treatments (4 papers). R. H. Strasser is often cited by papers focused on Acute Kidney Injury Research (5 papers), Cardiovascular Function and Risk Factors (4 papers) and Cardiac Valve Diseases and Treatments (4 papers). R. H. Strasser collaborates with scholars based in Germany, United States and Switzerland. R. H. Strasser's co-authors include W. Kübler, Vera Regitz‐Zagrosek, C. Bossaller, Eckart Fleck, Steffen Kolschmann, Carsten Wunderlich, S. Schüler, Roland Hetzer, Rainer Marquetant and Marian Christoph and has published in prestigious journals such as Circulation, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

R. H. Strasser

33 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. H. Strasser Germany 12 289 107 81 79 66 36 470
Romuald Lango Poland 12 210 0.7× 144 1.3× 147 1.8× 41 0.5× 29 0.4× 41 523
Yao-Chang Wang Taiwan 13 176 0.6× 135 1.3× 108 1.3× 99 1.3× 52 0.8× 26 436
Jeanette Koller-Strametz Austria 8 307 1.1× 104 1.0× 39 0.5× 106 1.3× 39 0.6× 9 468
Sveneric Svensson Sweden 13 233 0.8× 202 1.9× 57 0.7× 50 0.6× 60 0.9× 20 511
A. J. Drake‐Holland United Kingdom 14 380 1.3× 92 0.9× 97 1.2× 48 0.6× 23 0.3× 38 604
H. Schad Germany 16 286 1.0× 336 3.1× 60 0.7× 111 1.4× 68 1.0× 51 729
Martina Crivellari Italy 12 218 0.8× 177 1.7× 39 0.5× 73 0.9× 78 1.2× 36 581
Henrik Vase Denmark 14 265 0.9× 72 0.7× 129 1.6× 79 1.0× 48 0.7× 31 499
Dmitry Ponomarev Russia 12 414 1.4× 99 0.9× 24 0.3× 112 1.4× 71 1.1× 53 629
Marc S. Visner United States 11 320 1.1× 72 0.7× 116 1.4× 68 0.9× 62 0.9× 20 545

Countries citing papers authored by R. H. Strasser

Since Specialization
Citations

This map shows the geographic impact of R. H. Strasser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. H. Strasser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. H. Strasser more than expected).

Fields of papers citing papers by R. H. Strasser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. H. Strasser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. H. Strasser. The network helps show where R. H. Strasser may publish in the future.

Co-authorship network of co-authors of R. H. Strasser

This figure shows the co-authorship network connecting the top 25 collaborators of R. H. Strasser. A scholar is included among the top collaborators of R. H. Strasser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. H. Strasser. R. H. Strasser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ibrahim, Karim, Marian Christoph, Christian Pfluecke, et al.. (2014). High rates of prasugrel and ticagrelor non-responder in patients treated with therapeutic hypothermia after cardiac arrest. Resuscitation. 85(5). 649–656. 90 indexed citations
3.
Kolschmann, Steffen, Karim Ibrahim, & R. H. Strasser. (2012). Primary aortic sarcoma with multiple metastatic sites. European Heart Journal. 33(16). 1995–1995. 3 indexed citations
4.
Guenther, Michael, Steffen Kolschmann, Thomas Rauwolf, et al.. (2012). Implantable cardioverter defibrillator lead implantation in patients with a persistent left superior vena cava—feasibility, chances, and limitations: representative cases in adults. EP Europace. 15(2). 273–277. 12 indexed citations
5.
Speiser, Uwe, et al.. (2010). Feasibility of time resolved magnetic resonance imaging of contrast kinetics to identify severe tricuspid valve regurgitation. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 182(2). 1 indexed citations
6.
Schoen, Steffen P., et al.. (2009). Nomograms for severity of aortic valve stenosis using peak aortic valve pressure gradient and left ventricular ejection fraction. European Journal of Echocardiography. 10(4). 532–536. 1 indexed citations
7.
Simonis, Gregor, et al.. (2008). Right ventricular dilatation predicts survival after mitral valve repair in patients with impaired left ventricular systolic function. European Journal of Echocardiography. 10(2). 309–313. 16 indexed citations
8.
Strasser, R. H., et al.. (2007). A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension. Journal of Human Hypertension. 21(10). 780–787. 54 indexed citations
9.
Boscheri, Alessandra, et al.. (2007). Failure of ascorbic acid to prevent contrast-media induced nephropathy in patients with renal dysfunction. Clinical Nephrology. 68(11). 279–286. 51 indexed citations
10.
Braun, S., et al.. (2006). Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension. International Journal of Cardiology. 115(1). 67–72. 18 indexed citations
11.
Gerbert, Barbara, et al.. (2005). Schilddrüsenhormon und kardiovaskuläres System. DMW - Deutsche Medizinische Wochenschrift. 130(39). 2215–2219. 2 indexed citations
12.
Einsle, Franziska, et al.. (2005). Die Bedeutung von Herzangst in der interdisziplinären Diagnostik psychosomatischer Komorbidität bei Thoraxschmerzpatienten. PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie. 55(1). 1 indexed citations
13.
Aspelin, P., et al.. (2003). Nephrotoxic effects in high-risk patients undergoing angiography. ACC Current Journal Review. 12(3). 67–67. 2 indexed citations
14.
Aspelin, P., et al.. (2002). Nephrotoxicity in high-risk patients. A double-blind, randomized multicenter study of iso-osmolar and low-osmolar nonionic contrast media : The nephrotoxicity, high risk, iso-osmolar, contrast media (NEPHRIC) study.. The American Journal of Cardiology. 90. 2 indexed citations
15.
Braun, Martin, et al.. (2002). Katheterinterventioneller Verschluss eines ventiloffenen Foramen ovale über eine zusätzliche transseptale Punktion. Zeitschrift für Kardiologie. 91(8). 659–662. 6 indexed citations
16.
Aspelin, P., et al.. (2002). Nephrotoxicity in High-Risk Patients. A double-blind, randomized multicenter study of Iso-Osmolar and low-osmolar nonionic contrast media. 143–143. 1 indexed citations
17.
Pohl, Julia, et al.. (2000). Fatty acid transporters in plasma membranes of cardiomyocytes in patients with dilated cardiomyopathy.. PubMed. 5(10). 438–42. 11 indexed citations
18.
Kübler, W. & R. H. Strasser. (1994). Signal transduction in myocardial ischaemia*. European Heart Journal. 15(4). 437–445. 39 indexed citations
19.
Strasser, R. H. & Rainer Marquetant. (1991). Sensitization of the  -adrenergic system in acute myocardial ischaemia by a protein kinase C-dependent mechanism. European Heart Journal. 12(suppl F). 48–53. 15 indexed citations
20.
Regitz‐Zagrosek, Vera, C. Bossaller, R. H. Strasser, et al.. (1990). Metabolic Alterations in End-Stage and Less Severe Heart Failure — Myocardial Carnitine Decrease. Clinical Chemistry and Laboratory Medicine (CCLM). 28(9). 611–7. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Romuald Lango Breakdown of academic impact, for papers by Yao-Chang Wang Breakdown of academic impact, for papers by Jeanette Koller-Strametz Breakdown of academic impact, for papers by Sveneric Svensson Breakdown of academic impact, for papers by A. J. Drake‐Holland Breakdown of academic impact, for papers by H. Schad Breakdown of academic impact, for papers by Martina Crivellari Breakdown of academic impact, for papers by Henrik Vase Breakdown of academic impact, for papers by Dmitry Ponomarev Breakdown of academic impact, for papers by Marc S. Visner
Rankless by CCL
2026